Results 251 to 260 of about 249,410 (353)
Identification of novel gene expression programs in thrombin-stimulated hepatic stellate cells. [PDF]
Mac NA +5 more
europepmc +1 more source
Human SART3 has two RRM domains to engage with U6 snRNA for spliceosome recycling. This study reports solution structures of SART3 RRM domains and investigates the interaction between RRM and U6 snRNA. SART3 binds to the asymmetric bulge of U6 snRNA as a dimer via conserved positively charged surfaces.
Iktae Kim +8 more
wiley +1 more source
Emicizumab, the factor VIII mimetic bispecific monoclonal antibody: effects on thrombin generation and thromboelastometry. [PDF]
Tripodi A +6 more
europepmc +1 more source
TGFβ enhances platelet–breast‐cancer‐cell interaction and promotes platelet aggregation
TGFβ stimulation promotes EMT in MCF7 cells, increasing their ability to bind, activate, and aggregate PLT. This effect involves the upregulation of adhesion molecules Integrin‐αv and Galectin‐3. Inhibiting Integrin‐αv or Galectin‐3, through Cilengitide and GB1103, reduces PLT adhesion to MCF7 and PLT aggregation, suggesting a mechanism linking TGFβ ...
Margherita Genitoni +7 more
wiley +1 more source
Serine/threonine kinase 33 mediates thrombin-induced interleukin-8 release from human lung epithelial cells in severe asthma. [PDF]
Cheng WH +9 more
europepmc +1 more source
Performance Verification of High Sensitivity Analyzer for TAT, PIC, TM, and t-PAIC. [PDF]
Liu Y +8 more
europepmc +1 more source
ABSTRACT Introduction The bispecific monoclonal antibody emicizumab was approved for prophylactic treatment of congenital haemophilia A (HA) in Japan in 2018. Aim To monitor long‐term safety and effectiveness of emicizumab, including appropriate concomitant use of bypassing agents (BPAs), in Japanese patients with congenital HA with inhibitors who ...
Midori Shima +7 more
wiley +1 more source
Tissue transglutaminase drives fibrin β-chain cross-linking: a novel fibrin modification observed in patients with trauma. [PDF]
Boateng NKK +9 more
europepmc +1 more source
ABSTRACT Introduction Coagulation testing in haemophilia A is limited by the scarcity of testing facilities capable of performing relevant assays. This issue incentivized the development of the EnzySystem for haemophilia A, a near‐patient testing platform aimed to measure Factor VIII activity and thrombin generation simultaneously within 1 h from 100 ...
Aernoud P. Bavinck +8 more
wiley +1 more source

